Abstract:Background: Reduced endometrium thickness and receptivity are two important reasons for recurrent implantation failure (RIF). In order to elucidate differences between these two types of endometrial defects in terms of molecular signatures, cellular interactions, and structural changes, we systematically investigated the single-cell transcriptomic atlas across three distinct groups: RIF patients with thin endometrium (≤ 6 mm, TE-RIF), RIF patients with normal endometrium thickness (≥ 8 mm, NE-RIF), and fertile individuals (Control). Methods: The late proliferative and mid-secretory phases of the endometrium were collected from three individuals in the TE-RIF group, two in the NE-RIF group, and three in the control group. The study employed a combination of advanced techniques. Single-cell RNA sequencing (scRNA-seq) was utilized to capture comprehensive transcriptomic profiles at the single-cell level, providing insights into gene expression patterns within specific cell types. Scanning and transmission electron microscopy were employed to visualize ultrastructural details of the endometrial tissue, while hematoxylin and eosin staining facilitated the examination of tissue morphology and cellular composition. Immunohistochemistry techniques were also applied to detect and localize specific protein markers relevant to endometrial receptivity and function. Results: Through comparative analysis of differentially expressed genes among these groups and KEGG pathway analysis, the TE-RIF group exhibited notable dysregulations in the TNF and MAPK signaling pathways, which are pivotal in stromal cell growth and endometrial receptivity. Conversely, in the NE-RIF group, disturbances in energy metabolism emerged as a primary contributor to reduced endometrial receptivity. Additionally, using CellPhoneDB for intercellular communication analysis revealed aberrant interactions between epithelial and stromal cells, impacting endometrial receptivity specifically in the TE-RIF group. Conclusion: Overall, our findings provide valuable insights into the heterogeneous molecular pathways and cellular interactions associated with RIF in different endometrial conditions. These insights may pave the way for targeted therapeutic interventions aimed at improving endometrial receptivity and enhancing reproductive outcomes in patients undergoing ART. Further research is warranted to validate these findings and translate them into clinical applications for personalized fertility treatments. Trial registration: Not applicable.

Alterations in Vaginal Microbiota and Associated Metabolome in Women with Recurrent Implantation Failure

Characterization of the vaginal microbiota in infertile women with repeated implantation failure

Altered Endometrial Microbiota Profile Is Associated With Poor Endometrial Receptivity of Repeated Implantation Failure

Changes in the Vaginal Microbiota Associated with Primary Ovarian Failure

Clinical Relevance of Vaginal and Endometrial Microbiome Investigation in Women with Repeated Implantation Failure and Recurrent Pregnancy Loss

The Clinical Characteristics of Women with Recurrent Implantation Failure

Unlocking the Uterine Code: Microbiota, Immune Cells, and Therapy for Recurrent Reproductive Failure

The Dynamics of the Vaginal Microbiome During Infertility Therapy with in Vitro Fertilization-Embryo Transfer

Altered microRNA Profiles of Extracellular Vesicles Secreted by Endometrial Cells from Women with Recurrent Implantation Failure

Innate and Adaptive Immune Dysregulation in Women with Recurrent Implantation Failure

Clinical application of the endometrial microbiota test combined with personalized treatment in patients with repeated implantation failure

Varied cellular abnormalities in thin vs. normal endometrium in recurrent implantation failure by single-cell transcriptomics

Immune profiling and RNA-seq uncover the cause of partial unexplained recurrent implantation failure

Chronic endometritis and the endometrial microbiota: implications for reproductive success in patients with recurrent implantation failure

Does the uterine microbiota affect the reproductive outcomes in women with recurrent implantation failures?

Recurrent Implantation Failure: Bioinformatic Discovery of Biomarkers and Identification of Metabolic Subtypes.

Alterations of Cytokine Profiles in Patients With Recurrent Implantation Failure

Narrative Review of Multifaceted Approaches to Managing Recurrent Implantation Failure: Insights and Innovations

Integrated Transcriptomic Analysis Reveals Dysregulated Immune Infiltration and Pro-Inflammatory Cytokines in the Secretory Endometrium of Recurrent Implantation Failure Patients

Understanding the Role of Female Genital Tract Microbiome in Recurrent Implantation Failure

Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure